A Study Of Peripartum Cardiomyopathy In Nigeria

Overview

About this study

The purpose of this study is to examine the association between AI-derived digital biomarkers and serum-based markers of epigenetic aging. Describe the genetic profile of PPCM among women in Nigeria.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  • Stated willingness to comply with all study procedures and availability for the duration of the study.

  • Female, aged 18 – 49 years a

  • Diagnosed with PPCM with echocardiogram images available for review b

  • Currently pregnant or postpartum (up to 48 months following delivery)

  • Ability of subject or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document

a. Among cases, we will consider age at the time of PPCM diagnosis

b. Applies to cases only and not controls. Controls would ideally not have a diagnosis of PPCM.

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in this study:

  • Acute severe illness (e.g. hospital admission with cardiogenic shock) with limited capacity communicate adequately with study team

  • Presence of significant conduction abnormalities on the resting ECG. This includes atrial or ventricular pacing artifacts, pacemaker dependence, or severely abnormal QRS morphology on ECG tracings (including left bundle branch block and right bundle branch block)

  • Complex congenital heart disease such as single ventricle physiology or significant shunts with cardiac structural changes (repaired and unrepaired)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/18/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Demilade Adedinsewo, M.B., Ch.B.

Open for enrollment

Contact information:

Demilade Adedinsewo

9049530859

adedinsewo.demilade@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20609111

Mayo Clinic Footer